About > Our Story
瑞士巴塞尔
  • 2011/12Hua Medicine successfully introduced innovative medicine form multinational company and was since globally recognized
中国南京
  • 2017/05HMS5552 officially initiated phase III clinical trial
中国北京
  • 2017/04HMS5552 was approved by CFDA to serve as a pilot drug under MAH System
  • 2017/10Hua Medicine Beijing office launched
美国旧金山
  • 2015/01Hua Medicine Raises $25 Million in Series B Financing
中国上海
  • 2011/06Hua Medicine (Shanghai) Ltd. was established
美国马里兰
  • 2015/04Maryland, USA American Food and Drug Administration officially approved the ld clinical trial of HMS5552 (the medicines first tap into American patients)
美国新泽西
  • 2016/06New Jersey, USA HMS5552 successfully accomplished ld clinical trial

Our Story

  • 2011/06Hua Medicine (Shanghai) Ltd. was established
  • 2011/12Hua Medicine successfully introduced innovative medicine form multinational company and was since globally recognized
  • 2012/02Project “Hua Medicine-Original Innovative New Medicine for Diabetes” kicked off in Zhangjiang, Pudong, Shanghai
  • 2012/11Original innovative new medicine for diabetes went through clinical research and results were submitted to The State Food and Drug Administration
  • 2013/02Project for Central Nervous System (CNS) related diseases completed preclinical pharmacodynamics and safety evaluation and the first Generation of mGluR5 NAM / PCT was submitted to apply for patent of invention to World Intellectual Property Organization
  • 2013/08HMS5552 as a new medicine for diabetes acquired approval of clinical research from The State Food and Drug Administration
  • 2013/09Innovative diabetes drug HMS552 started Phase I clinical study in China
  • 2013/11HMS5552 successfully accomplished the la stage of study into safety, tolerability and pharmacokinetics in a single oral dose by healthy adults
  • 2014/09HMS5552 successfully accomplished the lb stage of study into safety, tolerability and pharmacokinetics in a single oral dose by healthy adults.
  • 2015/01HMS5552 successfully accomplished the lc stage of study into drug action mechanism and pharmacodynamics
  • 2015/04American Food and Drug Administration officially approved the ld clinical trial of HMS5552 (the medicines first tap into American patients)
  • 2015/09HMS5552 II/III phase clinical trial was approved and volunteer recruitment started
  • 2016/09HMS5552 successfully completed phase II clinical trial
  • 2017/04HMS5552 was approved by The State Food and Drug Administration to serve as a pilot drug under Marketing Authorization Holder System
  • 2017/05HMS5552 officially initiated phase III clinical trial
  • 2017/10Hua Medicine Beijing office launched

Copyright © 2018 Hua Medicine, All Rights Reserved

沪ICP备14036654号